first generation glp 1 Timeline of GLP-1 discovery and clinical development. (a) Key events in Transforming obesity: The advancement of
Description
Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) is a 39-amino acid triple-receptor peptide

Who is a good candidate for GLP-1 Medical Weight Loss

Aronoff, H

doi: 10.1177/19322968221147937

35 In our study only glucagon z-score was positively associated with total cholesterol and marginally significant for triglyceride z-score
Amount of Weight to Lose and Metabolic Profile For patients with significant weight to lose, particularly those with a BMI above 35 or with insulin resistance and elevated fasting glucose, tirzepatide's stronger efficacy data and dual metabolic mechanism may make it the more appropriate first choice